作者: Deborah Schrag
DOI: 10.1056/NEJMP048143
关键词: Gastroenterology 、 Medicine 、 Colorectal cancer 、 Rectal disease 、 Cetuximab 、 Regimen 、 Chemotherapy 、 Irinotecan 、 Colonic disease 、 Internal medicine
摘要: The irinotecan and cetuximab regimen costs approximately $30,790. How should we determine whether these interventions are worth their immense cost? Dr. Deborah Schrag responds.